Saturday 7 November 2026 Export AGIO’s income statement to Excel — free account

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $54.0 million, up 48.0% from fiscal 2024.

Revenue: +330.0%
EPS: +38.8%
Free cash flow: +32.6%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

29.41 1.14 +4.03%

Follow AGIO

Alert me

Market cap: $1.7B
P/E: 0.0×
Fwd P/E: −5.1×
Dividend yield: —
F-score: 3/9
Altman Z: 8.12
Beneish M: −1.72
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 5 Nov
ROE Full definition →	+8 more TTM periods Free account	(30.20%)	(32.82%)	(34.34%)	(32.95%)
Piotroski F-Score Full definition →		3	4	4	4
ROA Full definition →		(27.89%)	(30.84%)	(31.89%)	(30.44%)
ROIC Full definition →		(87.12%)	(79.88%)	(70.24%)	(75.02%)
Return on Tangible Assets Full definition →		(47.41%)	(53.73%)	(62.56%)	(54.45%)
Average Days of Receivables Full definition →		71.46	89.15	74.65	0.00
Free Cash Flow per Share Full definition →		(6.51)	(6.54)	(6.14)	(5.63)
Free Cash Flow Full definition →		(377.29)	(384.73)	(365.25)	(335.97)
Capital Expenditures Full definition →		(4.32)	(4.32)	(4.66)	(4.28)
Other line items
Cash ROIC Full definition →		(18.43%)	(20.84%)	(22.22%)	(20.88%)
Accounts Receivable Turnover Full definition →		7.36	6.78	7.84	0.00
Accounts Payable Turnover Full definition →		0.36	0.48	0.46	0.44
Inventory Turnover Full definition →		0.21	0.20	0.26	0.00
Average Days of Payables Full definition →		1,055.88	762.68	757.77	834.28
Days of Inventory on Hand Full definition →		1,893.74	1,946.61	1,397.88	0.00
Tax Rate Full definition →		0.00	0.00	0.00	—
Research and Development Expense of Revenue Full definition →		628.44%	526.80%	362.78%	243.85%
Selling, General and Administrative Expense of Revenue Full definition →		333.68%	283.21%	195.99%	147.68%
Share Based Compensation of Revenue Full definition →		97.27%	85.90%	58.96%	44.22%
Operating CF/Net income Full definition →		0.90	0.90	0.88	0.89
Depreciation/Fixed assets Full definition →		(0.19)	(0.16)	(0.03)	0.05
Capex/Depreciation Full definition →		2.14	2.50	13.50	(8.83)
Revenue per Share Full definition →		0.93	1.12	1.65	2.36
Operating CF per Share Full definition →		(6.43)	(6.47)	(6.06)	(5.56)
Capex per Share Full definition →		(0.07)	(0.07)	(0.08)	(0.07)
Capex to Sales Full definition →		0.08	0.07	0.05	0.03

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly